When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials?

Annals of Internal Medicine

Volumn 144, Issue 11, 2006, Pages 850-855

  Lord, Sarah J ^a   Irwig, Les ^a,b   Simes, R John ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ACCURACY; ARTICLE; BREAST CANCER; CLINICAL TRIAL; DIAGNOSTIC TEST; HUMAN; INTERMETHOD COMPARISON; MEASUREMENT; MEDICAL PRACTICE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THERAPY; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; RANDOMIZED CONTROLLED TRIAL; STANDARD;

DIAGNOSTIC TECHNIQUES AND PROCEDURES; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS; SENSITIVITY AND SPECIFICITY;

EID: 33745007128     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-144-11-200606060-00011     Document Type: Article

References (18)

1. Fryback DG, Thornbury JR. The efficacy of diagnostic imaging. Med Decis Making. 1991;11:88-94.
2. Guyatt GH, Tugwell PX, Feeny DH, Haynes RB, Drummond M. A framework for clinical evaluation of diagnostic technologies. CMAJ. 1986;134:587-94.
3. Barratt A, Irwig L, Glasziou P, Cumming RG, Raffle A, Hicks N, et al. Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group. JAMA. 1999;281:2029-34.
4. Busse R, Orvain J, Velasco M, Perleth M, Drummond M, Gurtner F, et al. Best practice in undertaking and reporting health technology assessments. Working group 4 report. Int J Technol Assess Health Care. 2002;18:361-422.
5. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20:21-35.
6. Biesheuvel CJ, Grobbee DE, Moons KG. Distraction from randomization in diagnostic research. Ann Epidemiol. 2006.
7. Dauzat M, Laroche JP, Deklunder G, Ayoub J, Quére I, Lopez FM, et al. Diagnosis of acute lower limb deep venous thrombosis with ultrasound: trends and controversies. J Clin Ultrasound. 1997;25:343-58.
8. Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med. 1999;130:800-9.
9. Ouyang DL, Chen JJ, Getzenberg RH, Schoen RE. Noninvasive testing for colorectal cancer: a review. Am J Gastroenterol. 2005;100:1393-403.
10. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet. 1998;351:1451-67.
11. Fletcher JG, Johnson CD, Welch TJ, MacCarty RL, Ahlquist DA, Reed JE, et al. Optimization of CT colonography technique: prospective trial in 180 patients. Radiology. 2000;216:704-11.
12. Otvos JD, Jeyarajah EJ, Cromwell WC. Measurement issues related to lipoprotein.
13. Bailey KR. Generalizing the results of randomized clinical trials. Control Clin Trials. 1994;15:15-23.
14. Irwig L, Bossuyt P, Glasziou P, Gatsonis C, Lijmer J. Designing studies to ensure that estimates of test accuracy are transferable. BMJ. 2002;324:669-71.
15. Koelemay MJ, Lijmer JG, Stoker J, Legemate DA, Bossuyt PM. Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a meta-analysis. JAMA. 2001;285:1338-45.
16. Irwig L, Houssami N, Armstrong B, Glasziou P. Evaluating new screening tests for breast cancer [Editorial]. BMJ. 2006;332:678-9.
17. Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345:311-8.
18. Bossuyt PM, Lijmer JG, Mol BW. Randomised comparisons of medical tests: sometimes invalid, not always efficient. Lancet. 2000;356:1844-7.